Amarin Corporation plc announced the appointment of Jonathan Provoost as the Company's new Executive Vice President, Chief Legal &Compliance Officer. He will join the Company on November 15, 2023. Mr. Provoost, who most recently served as Vice President, General Counsel and Chief Compliance Officer at Tris Pharma Inc., brings more than 20 years of corporate legal experience, having served most of his career in large and medium-sized pharmaceutical companies.

Mr. Provoosts broad experience in the legal profession includes serving as Chief Compliance Officer and General Counsel, management of intellectual property, general transactions, litigation, and various business activities. Prior to Tris, Jonathan served as General Counsel for Business Development &Licensing at Mallinckrodt Pharmaceuticals following a number of roles of increasing responsibility at the company. Earlier in his career, Mr. Provoost served in various legal roles for other pharmaceutical companies, including Ikaria Inc., Kos Pharmaceuticals and Bristol-Myers Squibb.

Jonathan earned his J.D. from Pace University School of Law, his M.B.A. from Lehigh University, and a B.S. in Chemistry from SUNY Oswego, in addition to serving in the U.S. Marine Corps Reserve. He is admitted to NY/NJ bars and is registered to practice before the U.S. Patent and Trademark Office (USPTO).